7Baggers
Quarterly
Annual
    Unit: USD2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 
      
                             
      net revenue
    116,193,000 114,565,000 91,409,000 109,735,000 93,100,000 92,894,000 70,650,000 85,918,000 70,384,000 68,980,000 48,420,000 53,135,000 46,913,000   34,783,000 35,243,000 15,213,000 26,296,000 9,946,000 1,309,000 1,488,000 1,077,000 494,000 201,000 
      cost of goods sold
    26,542,000 25,422,000 22,156,000 26,975,000 23,996,000 22,704,000 18,150,000 22,951,000 19,124,000 18,784,000 15,178,000 17,744,000 15,719,000 17,135,000 13,974,000 12,652,000 13,434,000 8,463,000 9,895,000 4,538,000 632,000 772,000 548,000 245,000 106,000 
      gross profit
    89,651,000 89,143,000 69,253,000 82,760,000 69,104,000 70,190,000 52,500,000 62,967,000 51,260,000 50,196,000 33,242,000 35,391,000 31,194,000 28,734,000 20,399,000 22,131,000 21,809,000 6,750,000 16,401,000 5,408,000 677,000 716,000 529,000 249,000 95,000 
      yoy
    29.73% 27.00% 31.91% 31.43% 34.81% 39.83% 57.93% 77.92% 64.33% 74.69% 62.96% 59.92% 43.03% 325.69% 24.38% 309.23% 3121.42% 842.74% 3000.38% 2071.89% 612.63%     
      qoq
    0.57% 28.72% -16.32% 19.76% -1.55% 33.70% -16.62% 22.84% 2.12% 51.00% -6.07% 13.45% 8.56% 40.86% -7.83% 1.48% 223.10% -58.84% 203.27% 698.82% -5.45% 35.35% 112.45% 162.11%  
      gross margin %
                 62.64% 59.35%           
      operating expenses
                             
      research and development
    13,491,000 12,792,000 11,056,000 9,714,000 8,167,000 8,949,000 8,056,000 8,103,000 7,936,000 7,135,000 11,236,000 10,182,000 8,648,000 9,098,000 9,369,000 8,140,000 7,748,000 6,398,000 6,884,000 6,233,000 4,855,000 4,874,000 4,219,000 4,783,000 3,898,000 
      general and administrative
    23,761,000 16,327,000 15,104,000 11,095,000 11,778,000 10,713,000 12,168,000 10,264,000 9,389,000 10,572,000 10,013,000 9,404,000 8,720,000 8,035,000 6,626,000 6,588,000 5,773,000 5,537,000 7,653,000 5,537,000 5,162,000 4,362,000 4,015,000 3,501,000 2,790,000 
      sales and marketing
    52,972,000 51,444,000 56,191,000 55,094,000 47,544,000 44,270,000 42,654,000 43,824,000 39,751,000 39,381,000 33,063,000 31,338,000 28,112,000 25,411,000 20,928,000 18,284,000 17,057,000 14,220,000 16,569,000 16,301,000 15,707,000 10,750,000 5,914,000 1,416,000 949,000 
      amortization of intangible assets
    2,221,000 2,247,000 2,254,000 2,261,000 2,302,000 2,279,000 2,222,000 2,271,000 2,317,000 2,332,000 2,463,000 2,147,000 2,216,000 2,200,000 678,000           
      acquisition-related costs
    3,474,000 2,652,000 3,827,000 3,530,000  602,000 1,766,000 2,114,000 8,242,000 12,205,000     4,414,000           
      acquired in-process research & development
         15,447,000                    
      total operating expenses
    95,919,000 85,462,000 88,432,000 81,694,000 69,791,000 82,260,000 66,866,000 66,576,000 67,635,000 71,625,000 56,775,000 53,071,000 47,696,000 44,744,000 42,015,000 33,012,000 30,578,000 26,155,000 31,106,000 28,071,000 25,724,000 19,986,000 14,148,000 9,700,000 7,637,000 
      income from operations
    -6,268,000 3,681,000 -19,179,000 1,066,000 -687,000 -12,070,000 -14,366,000 -3,609,000 -16,375,000 -21,429,000 -23,533,000 -17,680,000 -16,502,000 -16,010,000 -21,616,000 -10,881,000 -8,769,000 -19,405,000 -14,705,000 -22,663,000 -25,047,000 -19,270,000 -13,619,000 -9,451,000 -7,542,000 
      yoy
    812.37% -130.50% 33.50% -129.54% -95.80% -43.67% -38.95% -79.59% -0.77% 33.85% 8.87% 62.49% 88.19% -17.50% 47.00% -51.99% -64.99% 0.70% 7.97% 139.79% 232.10%     
      qoq
    -270.28% -119.19% -1899.16% -255.17% -94.31% -15.98% 298.06% -77.96% -23.58% -8.94% 33.11% 7.14% 3.07% -25.93% 98.66% 24.08% -54.81% 31.96% -35.11% -9.52% 29.98% 41.49% 44.10% 25.31%  
      operating margin %
                 -34.90% -62.89%           
      other income
    4,712,000 4,670,000 3,914,000 4,390,000 4,188,000 4,424,000 4,311,000 3,752,000 -397,000 -479,000 -246,000 27,000 -220,000 -5,842,000 -1,442,000 -467,000 -399,000 -378,000 90,000 -88,000 41,000 210,000 502,000 234,000 -196,000 
      interest and other income
    4,704,000 4,702,000 3,973,000 4,541,000 4,271,000 4,250,000 3,628,000 8,159,000 -1,898,000 -839,000 -289,000 102,000 -229,000 -5,849,000 -1,450,000 -445,000 -434,000 -443,000 -552,000 -562,000 -586,000 -629,000 -532,000   
      income before income tax (benefit) expense
    -1,556,000       143,000 -16,772,000 -21,908,000     -23,058,000           
      income tax (benefit) expense
    -1,535,000       -522,000 -520,000 -465,000     -555,000           
      net income
    -21,000 6,899,000 -19,112,000 6,574,000 3,928,000 -7,342,000 -9,248,000 665,000 -16,252,000 -21,443,000 -22,668,000 -15,166,000 -17,250,000 -25,148,000 -22,503,000 -11,348,000 -9,168,000 -19,783,000 -14,616,000 -22,751,000 -25,006,000 -19,061,000 -13,117,000 -9,665,000 -7,566,000 
      yoy
    -100.53% -193.97% 106.66% 888.57% -124.17% -65.76% -59.20% -104.38% -5.79% -14.73% 0.73% 33.64% 88.15% 27.12% 53.96% -50.12% -63.34% 3.79% 11.43% 135.40% 230.50%     
      qoq
    -100.30% -136.10% -390.72% 67.36% -153.50% -20.61% -1490.68% -104.09% -24.21% -5.40% 49.47% -12.08% -31.41% 11.75% 98.30% 23.78% -53.66% 35.35% -35.76% -9.02% 31.19% 45.32% 35.72% 27.74%  
      net income margin %
                 -54.83% -65.47%           
      foreign currency translation adjustment
    10,438,000 466,000 -1,152,000 8,644,000 -6,185,000 3,750,000 3,071,000 11,038,000 -12,057,000 -12,648,000 -4,920,000 352,000 -5,138,000 859,000 -2,202,000 183,000 99,000 -108,000 -177,000 153,000 -112,000 -43,000 -10,000 -10,000 -1,000 
      comprehensive income
    10,417,000 7,365,000                        
      net income per share
    0.14 -0.38 0.14 0.08 -0.15 -0.19 0.03 -0.34 -0.47 -0.5 -0.33 -0.38 -0.59 -0.57 -0.28 -0.24 -0.54 -0.43 -0.75 -0.89 -0.68 -0.47 3.46 -2.67 
      weighted-average shares used for eps calculation
    51,088,073 50,010,380 50,928,171 49,081,470 49,244,981 49,088,373 48,579,084 46,684,478 47,208,192 45,311,001 45,139,038 43,072,298 44,848,023 42,788,678 39,613,964 36,981,335 38,830,924 36,440,846 33,637,646 28,567,302 28,098,564 27,945,393 27,828,201 6,997,777 2,830,591 
      income before income tax benefit
     8,351,000 -15,265,000 -3,550,000 3,501,000 -7,646,000 -10,055,000    -23,779,000               
      income tax benefit
     1,452,000 3,847,000 -384,500 -427,000 -304,000 -807,000    -1,111,000               
      comprehensive loss
      -20,264,000 -3,006,500 -2,257,000 -3,592,000 -6,177,000 11,703,000 -28,309,000 -34,091,000 -27,588,000 -14,814,000 -22,388,000 -24,289,000 -24,705,000 -11,165,000 -9,069,000 -19,891,000 -14,793,000 -22,598,000 -25,118,000 -19,104,000 -13,127,000 -9,675,000 -7,567,000 
      interest income
           476,000 1,501,000 360,000 43,000 16,000 9,000 7,000 8,000 19,000 35,000 65,000 642,000 474,000 627,000 839,000 1,034,000 550,000 172,000 
      income before income tax expense
               -17,653,000 -16,722,000 -21,852,000  -11,348,000 -9,168,000 -19,783,000 -14,615,000 -22,751,000 -25,006,000 -19,060,000 -13,117,000 -9,665,000 -7,566,000 
      income tax expense
               -2,487,000 528,000 3,296,000     1,000   1,000    
      sacral neuromodulation net revenue
                 40,194,000 32,903,000           
      bulkamid net revenue
                 5,675,000 1,470,000           
      total net revenue
                 45,869,000 34,373,000           
      yoy
                             
      qoq
                 33.44%            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.